Experimental Anti-Viral MK-4482 To Treat COVID (Rocky Mountain)
Initial animal tests of a brand new anti-viral medicine has shown what it may treat or even prevent COVID-19. This could be the magic bullet which could defeat the anti-vaXXers and even the mutations. MK-4482 shows potential to prevent and treat SARS-CoV-2 infection. In a press release the NIH just published this information within the hour. " The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists. SARS-CoV-2 is the virus that causes COVID-19. MK-4482, delivered orally, is now in human clinical trials. Remdesivir, an antiviral drug already approved by the U.S. Food and Drug Administration for use against COVID-19, must be provided intravenously, making its use primarily limited to clinical settings. In their study, published in the journal Nature Communications , the scientists found MK-4482 treatment ef...